• Metronidazole Reprograms P. gingivalis Vesicles

  2026-09-17

  The reference study shows that sub-inhibitory metronidazole does more than leave Porphyromonas gingivalis partially suppressed: it increases extracellular-vesicle output, enriches vesicles with virulence factors, and intensifies endothelial injury. These findings offer a mechanistic explanation for why antibiotic exposure may not fully resolve the vascular consequences associated with periodontitis.

• Esculetin, CKLF1, and Post-Stroke Repair

  2026-09-17

  A 2025 Acta Pharmacologica Sinica study identifies CKLF1-mediated neutrophil recruitment as a mechanistic point through which esculetin improves recovery after experimental ischemic stroke. Using behavioral, MRI, molecular, cellular, and genetic approaches, the authors connect reduced CKLF1–CCR5 signaling with lower neutrophil infiltration and better neural repair.

• Miransertib in WecA-Informed Assay Design

  2026-09-16

  Miransertib can sharpen interpretation of host AKT signaling without being misidentified as a direct WecA inhibitor. This article translates new WecA membrane-enzyme methodology into a rigorous framework for separating bacterial target validation from host-cell pathway analysis.

• Pentoxifylline in Preterm Monocyte Hyperinflammation

  2026-09-16

  Schüller et al. showed that pentoxifylline suppresses LPS-driven monocyte activation in preterm infants through coordinated effects on surface phenotype, cytokine release, phagocytosis, and TLR4 signaling. The age-stratified in vitro design identifies stronger effects on selected preterm monocyte markers while highlighting why anti-inflammatory responses cannot be extrapolated directly from adults to neonates.

• AO/PI Double Staining Kit: Practical Workflow

  2026-09-15

  The AO/PI Double Staining Kit provides a rapid fluorescent screen for separating viable, apoptotic, and necrotic cell populations in a single sample. It is suitable for comparative cell viability assays and preliminary apoptosis or necrosis detection, but its color-based readout should not be treated as standalone proof of a specific cell-death pathway.

• A23187, Free Acid: An Assay Interpretation Guide

  2026-09-15

  A23187, free acid is a calcium ionophore for dissecting intracellular Ca2+ signaling, apoptosis, and stress responses. This guide combines mechanistic evidence with a practical assay framework for distinguishing growth inhibition from true cell killing.

• Eicosapentaenoic Acid as a Research Variable

  2026-09-14

  Explore Eicosapentaenoic Acid as a controlled experimental perturbation rather than a generic omega-3 supplement. This article connects membrane biology, cardiovascular assays, and the latest arachidonic acid immunity findings to improve EPA study design and interpretation.

• Fosinopril Sodium as a Mechanistic Benchmark

  2026-09-14

  Fosinopril sodium offers a rigorous ACE inhibitor benchmark for hypertension research and cardiovascular disease models. This article shows how its prodrug pharmacology, renal-hepatic disposition, and pathway specificity can sharpen assay design informed by catalpol research.

• ABT-888 (Veliparib) in DNA Repair Assays

  2026-09-13

  ABT-888 (Veliparib) provides a practical way to interrogate PARP1/2-dependent DNA repair inhibition and chemotherapy or radiation sensitization. Its strongest use cases span colorectal cancer research, MSI tumor models, combination screens, and mechanistic studies of resistance to DNA damage response therapies.

• Ruthenium Red and the Next Calcium Signaling Paradigm

  2026-09-12

  Mechanical stress, cytoskeletal architecture, calcium transport, and autophagy are increasingly understood as connected layers of cellular adaptation. This thought-leadership article examines how Ruthenium Red can help translational researchers test that connection, while defining its value, limitations, workflow requirements, and relevance to inflammation and mitochondrial calcium biology.

• MVC Activates RhoA/ROCK1 to Open Tight Junctions

  2026-09-12

  Ren and colleagues show that Minute Virus of Canines (MVC) uses a VP2–ROCK1 interaction to activate the RhoA/ROCK1/MLC2 axis, contract the actomyosin network, and disrupt tight junction organization. The study identifies occludin as a potential co-receptor and links host barrier remodeling to productive viral infection, providing a mechanistic framework for antiviral investigation.

• Selective Recovery of Moraxella from Bovine Specimens

  2026-09-11

  Laura G. Leger’s 2025 University of Nebraska–Lincoln thesis developed Moraxella Selective Vancomycin Agar (MSVA) to reduce contaminating bacterial growth and improve recovery of Moraxella spp. from bovine ocular specimens. The work also characterized previously unresolved isolates, expanding the known diversity of Moraxella associated with cattle and providing a stronger basis for studying infectious bovine keratoconjunctivitis.

• KX2-391 Analogues Reveal a Shift in Kinase Biology

  2026-09-11

  The 2022 Frontiers in Oncology study used scaffold hopping to test whether KX2-391 analogues retained Src and tubulin mechanisms or acquired different kinase activities. Its lead compound, 4e, preferentially affected leukemia cell lines and showed strong ERK1/2 suppression without relying on Src inhibition or tubulin polymerization, providing a useful framework for mechanism-led analogue design.

• FAM83A, CK1, and White Adipocyte Differentiation

  2026-09-10

  The reference study identifies FAM83A as a regulator of white adipocyte differentiation that connects casein kinase 1 activity with mitochondrial maintenance. Using adipose-targeted sgRNA/Cas9 delivery, the authors show that suppressing Fam83a reduces adipose expansion, disrupts mitochondrial function, and limits lipid accumulation in cells and mice.

• Carrier-Platin and ROS-Driven Cancer Cell Death

  2026-09-10

  The Biomaterials study introduces carrier-platin, a poly(amino acid) platform containing ultrasmall platinum nanoparticles that generates a rapid intracellular ROS burst. Its reported cell death mechanism is distinct from apoptosis and ferroptosis, does not depend on DNA damage, and shows activity across cancer models including multidrug-resistant disease.

8103 records 1/541 page Next 12345 下5页 Last page